Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

This case report describes how eculizumab reversed neurologic impairment and improved renal damage in severe atypical hemolytic uremic syndrome. A 50-year-old female, after presenting with diarrhea and abdominal pain, developed pancolitis, acute renal failure, and thrombocytopenia. The patient under...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohanian, Maro, Cable, Christian, Halka, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262387/
https://www.ncbi.nlm.nih.gov/pubmed/22287852
http://dx.doi.org/10.2147/CPAA.S17904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262387/
https://www.ncbi.nlm.nih.gov/pubmed/22287852
http://dx.doi.org/10.2147/CPAA.S17904

Ejemplares similares